These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 28722022)

  • 1. Opioid Release after High-Intensity Interval Training in Healthy Human Subjects.
    Saanijoki T; Tuominen L; Tuulari JJ; Nummenmaa L; Arponen E; Kalliokoski K; Hirvonen J
    Neuropsychopharmacology; 2018 Jan; 43(2):246-254. PubMed ID: 28722022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aerobic exercise modulates anticipatory reward processing via the μ-opioid receptor system.
    Saanijoki T; Nummenmaa L; Tuulari JJ; Tuominen L; Arponen E; Kalliokoski KK; Hirvonen J
    Hum Brain Mapp; 2018 Oct; 39(10):3972-3983. PubMed ID: 29885086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aerobic Fitness Is Associated with Cerebral μ-Opioid Receptor Activation in Healthy Humans.
    Saanijoki T; Kantonen T; Pekkarinen L; Kalliokoski K; Hirvonen J; Malén T; Tuominen L; Tuulari JJ; Arponen E; Nuutila P; Nummenmaa L
    Med Sci Sports Exerc; 2022 Jul; 54(7):1076-1084. PubMed ID: 35195103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered central micro-opioid receptor binding after psychological trauma.
    Liberzon I; Taylor SF; Phan KL; Britton JC; Fig LM; Bueller JA; Koeppe RA; Zubieta JK
    Biol Psychiatry; 2007 May; 61(9):1030-8. PubMed ID: 16945349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low- and high-frequency transcutaneous electrical acupoint stimulation induces different effects on cerebral μ-opioid receptor availability in rhesus monkeys.
    Xiang XH; Chen YM; Zhang JM; Tian JH; Han JS; Cui CL
    J Neurosci Res; 2014 May; 92(5):555-63. PubMed ID: 24482187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central μ-Opioidergic System Activation Evoked by Heavy and Severe-Intensity Cycling Exercise in Humans: a Pilot Study Using Positron Emission Tomography with 11C-Carfentanil.
    Hiura M; Sakata M; Ishii K; Toyohara J; Oda K; Nariai T; Ishiwata K
    Int J Sports Med; 2017 Jan; 38(1):19-26. PubMed ID: 28073122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of human affective responses by anterior cingulate and limbic mu-opioid neurotransmission.
    Zubieta JK; Ketter TA; Bueller JA; Xu Y; Kilbourn MR; Young EA; Koeppe RA
    Arch Gen Psychiatry; 2003 Nov; 60(11):1145-53. PubMed ID: 14609890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mu-opioid receptor binding measured by [11C]carfentanil positron emission tomography is related to craving and mood in alcohol dependence.
    Bencherif B; Wand GS; McCaul ME; Kim YK; Ilgin N; Dannals RF; Frost JJ
    Biol Psychiatry; 2004 Feb; 55(3):255-62. PubMed ID: 14744466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imaging brain mu-opioid receptors in abstinent cocaine users: time course and relation to cocaine craving.
    Gorelick DA; Kim YK; Bencherif B; Boyd SJ; Nelson R; Copersino M; Endres CJ; Dannals RF; Frost JJ
    Biol Psychiatry; 2005 Jun; 57(12):1573-82. PubMed ID: 15953495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low μ-Opioid Receptor Status in Alcohol Dependence Identified by Combined Positron Emission Tomography and Post-Mortem Brain Analysis.
    Hermann D; Hirth N; Reimold M; Batra A; Smolka MN; Hoffmann S; Kiefer F; Noori HR; Sommer WH; Reischl G; la Fougère C; Mann K; Spanagel R; Hansson AC
    Neuropsychopharmacology; 2017 Feb; 42(3):606-614. PubMed ID: 27510425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temperament trait Harm Avoidance associates with μ-opioid receptor availability in frontal cortex: a PET study using [(11)C]carfentanil.
    Tuominen L; Salo J; Hirvonen J; Någren K; Laine P; Melartin T; Isometsä E; Viikari J; Raitakari O; Keltikangas-Järvinen L; Hietala J
    Neuroimage; 2012 Jul; 61(3):670-6. PubMed ID: 22484309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Building up analgesia in humans via the endogenous μ-opioid system by combining placebo and active tDCS: a preliminary report.
    DosSantos MF; Martikainen IK; Nascimento TD; Love TM; DeBoer MD; Schambra HM; Bikson M; Zubieta JK; DaSilva AF
    PLoS One; 2014; 9(7):e102350. PubMed ID: 25029273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Placebo effects on human mu-opioid activity during pain.
    Wager TD; Scott DJ; Zubieta JK
    Proc Natl Acad Sci U S A; 2007 Jun; 104(26):11056-61. PubMed ID: 17578917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of chronic migraine attacks and their severity on the endogenous μ-opioid neurotransmission in the limbic system.
    Jassar H; Nascimento TD; Kaciroti N; DosSantos MF; Danciu T; Koeppe RA; Smith YR; Bigal ME; Porreca F; Casey KL; Zubieta JK; DaSilva AF
    Neuroimage Clin; 2019; 23():101905. PubMed ID: 31279240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feeding Releases Endogenous Opioids in Humans.
    Tuulari JJ; Tuominen L; de Boer FE; Hirvonen J; Helin S; Nuutila P; Nummenmaa L
    J Neurosci; 2017 Aug; 37(34):8284-8291. PubMed ID: 28747384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurotransmitters behind pain relief with transcranial magnetic stimulation - positron emission tomography evidence for release of endogenous opioids.
    Lamusuo S; Hirvonen J; Lindholm P; Martikainen IK; Hagelberg N; Parkkola R; Taiminen T; Hietala J; Helin S; Virtanen A; Pertovaara A; Jääskeläinen SK
    Eur J Pain; 2017 Oct; 21(9):1505-1515. PubMed ID: 28493519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association Between Placebo-Activated Neural Systems and Antidepressant Responses: Neurochemistry of Placebo Effects in Major Depression.
    Peciña M; Bohnert AS; Sikora M; Avery ET; Langenecker SA; Mickey BJ; Zubieta JK
    JAMA Psychiatry; 2015 Nov; 72(11):1087-94. PubMed ID: 26421634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Weight loss after bariatric surgery normalizes brain opioid receptors in morbid obesity.
    Karlsson HK; Tuulari JJ; Tuominen L; Hirvonen J; Honka H; Parkkola R; Helin S; Salminen P; Nuutila P; Nummenmaa L
    Mol Psychiatry; 2016 Aug; 21(8):1057-62. PubMed ID: 26460230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioural activation system sensitivity is associated with cerebral μ-opioid receptor availability.
    Karjalainen T; Tuominen L; Manninen S; Kalliokoski KK; Nuutila P; Jääskeläinen IP; Hari R; Sams M; Nummenmaa L
    Soc Cogn Affect Neurosci; 2016 Aug; 11(8):1310-6. PubMed ID: 27053768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response of the μ-opioid system to social rejection and acceptance.
    Hsu DT; Sanford BJ; Meyers KK; Love TM; Hazlett KE; Wang H; Ni L; Walker SJ; Mickey BJ; Korycinski ST; Koeppe RA; Crocker JK; Langenecker SA; Zubieta JK
    Mol Psychiatry; 2013 Nov; 18(11):1211-7. PubMed ID: 23958960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.